BNP Paribas Financial Markets’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $8.21M | Buy |
225,826
+48,975
| +28% | +$1.78M | ﹤0.01% | 1166 |
|
|
2025
Q1 | $6.4M | Buy |
176,851
+34,223
| +24% | +$1.24M | ﹤0.01% | 1162 |
|
|
2024
Q4 | $6M | Buy |
142,628
+113,797
| +395% | +$4.79M | ﹤0.01% | 1157 |
|
|
2024
Q3 | $1.6M | Sell |
28,831
-38,641
| -57% | -$2.15M | ﹤0.01% | 1536 |
|
|
2024
Q2 | $2.77M | Buy |
67,472
+47,579
| +239% | +$1.96M | ﹤0.01% | 1202 |
|
|
2024
Q1 | $929K | Sell |
19,893
-137,388
| -87% | -$6.41M | ﹤0.01% | 1935 |
|
|
2023
Q4 | $7.52M | Sell |
157,281
-56,994
| -27% | -$2.73M | 0.01% | 804 |
|
|
2023
Q3 | $7.64M | Buy |
214,275
+59,312
| +38% | +$2.11M | 0.01% | 709 |
|
|
2023
Q2 | $7.15M | Buy |
154,963
+56,435
| +57% | +$2.6M | 0.01% | 760 |
|
|
2023
Q1 | $3.95M | Buy |
98,528
+39,104
| +66% | +$1.57M | 0.01% | 1015 |
|
|
2022
Q4 | $2.75M | Sell |
59,424
-6,573
| -10% | -$305K | ﹤0.01% | 1110 |
|
|
2022
Q3 | $2.73M | Buy |
65,997
+51,148
| +344% | +$2.12M | ﹤0.01% | 1239 |
|
|
2022
Q2 | $886K | Sell |
14,849
-2,400
| -14% | -$143K | ﹤0.01% | 1718 |
|
|
2022
Q1 | $1.25M | Sell |
17,249
-29,571
| -63% | -$2.15M | ﹤0.01% | 1674 |
|
|
2021
Q4 | $3.94M | Buy |
46,820
+36,711
| +363% | +$3.09M | 0.01% | 1080 |
|
|
2021
Q3 | $912K | Buy |
10,109
+2,673
| +36% | +$241K | ﹤0.01% | 1898 |
|
|
2021
Q2 | $709K | Sell |
7,436
-31,113
| -81% | -$2.97M | ﹤0.01% | 1834 |
|
|
2021
Q1 | $4.39M | Buy |
38,549
+20,461
| +113% | +$2.33M | 0.01% | 922 |
|
|
2020
Q4 | $2.5M | Sell |
18,088
-16,605
| -48% | -$2.3M | ﹤0.01% | 1045 |
|
|
2020
Q3 | $2.85M | Buy |
34,693
+17,685
| +104% | +$1.45M | ﹤0.01% | 958 |
|
|
2020
Q2 | $1.33M | Sell |
17,008
-22,824
| -57% | -$1.79M | ﹤0.01% | 1190 |
|
|
2020
Q1 | $1.77M | Buy |
39,832
+18,286
| +85% | +$812K | ﹤0.01% | 1130 |
|
|
2019
Q4 | $920K | Buy |
21,546
+788
| +4% | +$33.7K | ﹤0.01% | 1516 |
|
|
2019
Q3 | $888K | Buy |
20,758
+3,366
| +19% | +$144K | ﹤0.01% | 1369 |
|
|
2019
Q2 | $1.1M | Sell |
17,392
-7,903
| -31% | -$502K | ﹤0.01% | 1198 |
|
|
2019
Q1 | $1.75M | Buy |
25,295
+13,158
| +108% | +$913K | ﹤0.01% | 1021 |
|
|
2018
Q4 | $528K | Buy |
12,137
+534
| +5% | +$23.2K | ﹤0.01% | 1212 |
|
|
2018
Q3 | $886K | Sell |
11,603
-3,892
| -25% | -$297K | ﹤0.01% | 1257 |
|
|
2018
Q2 | $1.19M | Sell |
15,495
-8,693
| -36% | -$668K | ﹤0.01% | 1175 |
|
|
2018
Q1 | $1.23M | Buy |
24,188
+2,852
| +13% | +$145K | ﹤0.01% | 1149 |
|
|
2017
Q4 | $990K | Buy |
21,336
+6,736
| +46% | +$312K | ﹤0.01% | 1429 |
|
|
2017
Q3 | $778K | Sell |
14,600
-109
| -0.7% | -$5.81K | ﹤0.01% | 1552 |
|
|
2017
Q2 | $914K | Buy |
14,709
+5,985
| +69% | +$372K | ﹤0.01% | 1408 |
|
|
2017
Q1 | $591K | Sell |
8,724
-456
| -5% | -$30.9K | ﹤0.01% | 1416 |
|
|
2016
Q4 | $645K | Buy |
9,180
+6,186
| +207% | +$435K | ﹤0.01% | 1318 |
|
|
2016
Q3 | $212K | Sell |
2,994
-5,285
| -64% | -$375K | ﹤0.01% | 1714 |
|
|
2016
Q2 | $405K | Buy |
8,279
+8,250
| +28,448% | +$404K | ﹤0.01% | 1601 |
|
|
2016
Q1 | $1.84K | Sell |
29
-7,807
| -100% | -$494K | ﹤0.01% | 2423 |
|
|
2015
Q4 | $879K | Sell |
7,836
-25
| -0.3% | -$2.8K | ﹤0.01% | 1150 |
|
|
2015
Q3 | $757K | Buy |
7,861
+4,874
| +163% | +$469K | ﹤0.01% | 1152 |
|
|
2015
Q2 | $306K | Buy |
2,987
+2,804
| +1,532% | +$287K | ﹤0.01% | 1526 |
|
|
2015
Q1 | $11.4K | Buy |
+183
| New | +$11.4K | ﹤0.01% | 2678 |
|
|
2014
Q4 | – | Sell |
-402
| Closed | -$22.8K | – | 2596 |
|
|
2014
Q3 | $22.8K | Buy |
+402
| New | +$22.8K | ﹤0.01% | 2619 |
|